Skip to content

Direxion Daily Magnificent 7 Bear 1X ETF

QQQDNYSE ArcaDirexionCThis fund multiplies its index's move each day and resets that multiple daily. Because daily returns compound, its long-run return can differ from the headline multiple.

$12.47+0.09 (+0.73%)

At close: Nov 2, 2026, 4:00 PM ET

Intraday session: up, 79 prints from 12.38 to 12.47. Range 12.15 to 12.47. Use the arrow keys to read each point.12.1512.2012.2512.3010 AM12 PM2 PM4 PM
Expense ratio
0.50%*
Fund size
$28M
1Y total return
0.0%
Yield · Last 12 months
3.32%
Holdings
3
Avg volume · 30D
68.1K sh
52W range
low $11.36high $15.52
Launched

*After a fee waiver that ends Sep 1, 2027. Without it: 1.08%.

The ETF.net QQQD Grade

Based on 4 of 6 pillars

C

Score 51 out of 100

Rank
21 of 54
Six-pillar profile for QQQD. Scores out of 100: Cost 50, Risk 67, Mission not scored, Tradability 43, Holdings not scored, Durability 38. Strongest: Risk (67). Weakest: Durability (38). Based on 4 of 6 pillars.

Score 51 of 100 falls in the C band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

  • Cost

    The fund’s net expense ratio, ranked against its category.
    C50 out of 100
    Rank 1 of 54
  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    Not scored
  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    B67 out of 100
    Rank 9 of 53
  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    C43 out of 100
    Rank 32 of 54
  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    Not scored
  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    D38 out of 100
    Rank 45 of 54

Our read on QQQD

ETF.net Research

In short

CFading the Magnificent 7 without a leverage multiplier: QQQD aims for -100% of the Indxx Magnificent 7 Index's daily move, one-for-one, at 0.50% net of a waiver through September 1, 2027.

Stated mandate

The fund seeks daily investment results equal to 100% of the inverse performance of the Indxx Magnificent 7 Index, before fees and expenses.

Why people hold it

  • One-for-one inverse, not 2x or 3x. A 1% index gain is designed to show up as roughly a 1% fund loss that day, and the reverse on down days, with no leverage stacked on top.direxion.com
  • 0.50% net of a waiver through September 1, 2027, below the category median and below the 0.95% at PSQ and DOG (net of waivers through September 30, 2027).
  • Surgical target: the short exposure is to the Magnificent 7 basket itself, not a broad Nasdaq index where those seven names get diluted by dozens of others.direxion.com
  • Despite launching in 2024, it stands in the upper half of a crowded bear and inverse peer group.

Worth knowing

  • Exposure resets every day. Hold longer than a day and compounding means the result can drift from the simple inverse of the index's move over that stretch.direxion.com
  • Seven mega-caps drive everything. One earnings surprise or one AI headline can move the whole basket, with no other holdings to soften it.direxion.com
  • That 0.50% is a net figure. Gross expenses run 1.08%, so the cost picture shifts if the waiver is not extended past September 1, 2027.

QQQD Performance

Launched Mar 7, 2024

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

Not enough history yet.Not enough history yet.Not enough history yet.
QQQD$10,004
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$11,146
Oct 31, 2025 to Nov 2, 2026. QQQD $10,004. SPY $11,146. Use the arrow keys to read each point.$9,000$10,000$11,000$12,000Oct 2025May 2026Nov 2026

Oct 31, 2025 – Nov 2, 2026

Returns run to the Nov 2, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for QQQD. Periods over one year show the average yearly return.
PeriodQQQD
Year to date−1.9%
1 month+6.8%
3 months−2.3%
1 year0.0%
3 yearsFund is under 3 years oldper yearNo data
5 yearsFund is under 5 years oldper yearNo data
10 yearsFund is under 10 years oldper yearNo data

With distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for QQQD
YearReturn barQQQD
2026 YTD−1.9%
2025−20.3%
2024−27.6%

Since listing, Mar 7, 2024

QQQD in the news

QQQD Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Nov 2, 2026.
3.32%Last 12 months
Payout per share
$0.41Last 12 months
Last payment
$0.10 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Quarterly

Distribution history

2024–2026

One bar per payment. 10 payments from 2024 to 2026 YTD. Jun 25, 2024 $0.32; Sep 24, 2024 $0.41; Dec 23, 2024 $0.15; Mar 25, 2025 $0.13; Jun 24, 2025 $0.20; Sep 23, 2025 $0.08; Dec 23, 2025 $0.15; Mar 24, 2026 $0.08; Jun 23, 2026 $0.09; Sep 22, 2026 $0.10. Use the arrow keys to read each point.202420252026YTD
Ex-datePay dateAmount per share
Sep 22, 2026Sep 29, 2026$0.10
Jun 23, 2026Jun 30, 2026$0.09
Mar 24, 2026Mar 31, 2026$0.08
Dec 23, 2025Dec 31, 2025$0.15
Sep 23, 2025Sep 30, 2025$0.08
Jun 24, 2025Jul 1, 2025$0.20
Mar 25, 2025Apr 1, 2025$0.13
Dec 23, 2024Dec 31, 2024$0.15
Sep 24, 2024Oct 1, 2024$0.41
Jun 25, 2024Jul 2, 2024$0.32

$10,000 in QQQD 1 year ago paid $325 in dividends.

QQQD Risk

This fund targets a multiple of the daily move of its index and resets daily. Hold it longer than one reset and compounding makes the return diverge from that target. In choppy markets it can lose value even when the index ends flat.

How much the fund’s monthly returns vary, scaled to a year.
21.1%
Annualised · 31 months to Oct 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
−1.14
vs 3-month T-bills · 31 months to Oct 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−51.4%
31 months · trough Oct 2026
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
−1.35
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

FMP measures it over up to five years of monthly returns.

QQQD Cost

Cheapest in Leveraged Inverse (2x & Other)

$9,979

On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.

  • QQQD 0.50%

    $9,979

$10,000
30 years

Cost over time

  • QQQD 0.50%
One line per fund, from year 0 to year 30. Use the arrow keys to read each point.$0$2K$4K$6K$8K$10K051015202530QQQD $9,979

Year by year

YearQQQD
10$900
20$3,460
30$9,979
How the 0.50% is worked out

Full fee 1.08%− waiver 0.58%= you pay 0.50%

The waiver ends Sep 1, 2027. After that the fee is 1.08% unless Direxion renews it. Source: prospectus, Mar 2026.

Other funds in Leveraged Inverse (2x & Other)